41100_2019_221_MOESM1_ESM.docx (43.06 kB)
Additional file 1: of Long-term safety and effectiveness of a continuous erythropoietin receptor activator (CERA) in patients with renal anemia: a prospective, observational, multicenter study
journal contribution
posted on 2019-06-06, 05:00 authored by Hidehiro Tabata, Hiroyuki Kanno, Ayako Murayama, Tadashi Ishii, Ryosuke Harada, Yukio UdagawaADRs leading to death. This table gives demographic and clinical characteristics of patients with an ADR whose outcome was death, and includes relevant details relating to their death. (DOCX 43 kb)